Skip to main content

and
  1. Article

    Open Access

    Anti-CD166/4-1BB chimeric antigen receptor T cell therapy for the treatment of osteosarcoma

    Chimeric antigen receptor (CAR)-engineered T cells have displayed outstanding performance in the treatment of patients with hematological malignancies. However, their efficacy against solid tumors has been lar...

    Yitian Wang, Wei Yu, Jian Zhu, Junjie Wang in Journal of Experimental & Clinical Cancer … (2019)